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Abstract
Background: Probiotic bacteria have been shown to modulate immune responses and could have therapeutic effects in
allergic and inflammatory disorders. However, the signaling pathways engaged by probiotics are poorly understood. We
have previously reported that a fermentation product from Bifidobacterium breve C50 (BbC50sn) could induce maturation,
high IL-10 production and prolonged survival of DCs via a TLR2 pathway. We therefore studied the roles of mitogen-
activated protein kinases (MAPK), glycogen synthase kinase-3 (GSK3) and phosphatidylinositol 3-kinase (PI3K) pathways on
biological functions of human monocyte-derived DCs treated with BbC50sn.
Methodology/Principal Findings: DCs were differentiated from human monocytes with IL-4 and GM-CSF for 5 days and
cultured with BbC50sn, lipopolysaccharide (LPS) or Zymosan, with or without specific inhibitors of p38MAPK (SB203580),
ERK (PD98059), PI3K (LY294002) and GSK3 (SB216763). We found that 1) the PI3K pathway was positively involved in the
prolonged DC survival induced by BbC50sn, LPS and Zymosan in contrast to p38MAPK and GSK3 which negatively
regulated DC survival; 2) p38MAPK and PI3K were positively involved in DC maturation, in contrast to ERK and GSK3 which
negatively regulated DC maturation; 3) ERK and PI3K were positively involved in DC-IL-10 production, in contrast to GSK3
that was positively involved in DC-IL-12 production whereas p38MAPK was positively involved in both; 4) BbC50sn induced
a PI3K/Akt phosphorylation similar to Zymosan and a p38MAPK phosphorylation similar to LPS.
Conclusion/Significance: We report for the first time that a fermentation product of a bifidobacteria can differentially
activate MAPK, GSK3 and PI3K in order to modulate DC biological functions. These results give new insights on the fine-
tuned balance between the maintenance of normal mucosal homeostasis to commensal and probiotic bacteria and the
specific inflammatory immune responses to pathogen bacteria.
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Introduction
The functional ability of dendritic cells (DCs) to generate specific
immune responses depends on the levels of costimulatory molecule
expression, cytokine production profile and survival of DCs [1,2].
These properties result from the integration of different intracellular
signals induced by the microenvironment, particularly exposure to
bacteria [3]. The immune system differentiates commensal bacteria
(resulting in no inflammatory responses) and pathogen bacteria
(resulting in inflammatory responses). One of the mechanisms
involved could be the integration of the differential signaling
induced by pathogen-recognition receptors (PRRs). Toll-Like
Receptors (TLRs) are PRRs expressed on DCs which recognize
pathogen-associated molecular patterns (PAMPs) from bacteria
corresponding to a broad spectrum of highly conserved microbial
structures [4]. TLRs are members of the IL-1 receptor (IL-1-R)
superfamily characterized by an intracytoplasmic Toll-IL-1 recep-
tor (TIR) domain, which mediates recruitment of the interleukin-1
receptor-associated kinase (IRAK) complex and downstream
signaling, via adapter molecules such as MyD88 [4]. It was initially
suggested that signaling through any of the TLRs instructs DCs to
promoteTh1 responses[5].However,TLRengagementcaninduce
a wide variety of signal transduction pathways to regulate the
nature, magnitude and duration of immune responses [2,6,7].
Probiotic bacteria have beenshown to modulate immune responses,
particularly mucosal immunity, and could have therapeutic effects
in allergic and inflammatory disorders [8–10]. In particular,
probiotic bacteria can interact with monocyte-derived DCs to
modulate their properties [11,12]. However, the signaling pathways
engaged by probiotics are poorly understood, particularly the ways
that differ from the inflammatory signaling pathways induced by
pathogenic bacteria [13–19]. We have previously reported that a
fermentation product from Bifidobacterium breve (BbC50sn) could
induce maturation, high IL-10 production and prolonged survival
PLoS ONE | www.plosone.org 1 July 2008 | Volume 3 | Issue 7 | e2753of DCs via a TLR2 pathway [20]. Nuclear factor-kappa B (NF-kB)
activation was involved in the maturation process of DCs treated by
BbC50sn (BbC50sn-DCs). However, IL-10 production and pro-
longed DC survival were independent of NF-kB, suggesting other
intracellularpathways induced byBbC50sn.Interestingly, BbC50sn
was able to suppress the biological effects of lipopolysaccharide
(LPS) on IL-12 production and DC apoptosis, confirming that
different signaling pathways are involved in DC biology. Moreover,
if NF-kB activation is required for DC maturation after TLR
engagement, other intracellular pathways, such as mitogen-
activated protein kinases (MAPK), glycogen synthase kinase-3
(GSK3) and phosphatidylinositol 3-kinase (PI3K) pathways, seem to
be critical in the biological functions of DCs [21–26]. We therefore
studied the roles of these kinases in the regulation of activation,
maturation and survival induced by BbC50sn on human monocyte-
derived DCs using specific inhibitors.
Results
Survival of BbC50sn, LPS and Zymosan-stimulated DC
was enhanced by PI3K, with an opposite effect of
p38MAPK and GSK3 signaling pathways
As previously described [20], BbC50sn induced prolonged DC
survival compared to LPS after 8 days of stimulation. Zymosan, a
TLR-2 agonist, induced a DC survival similar to that induced by
BbC50sn (Fig. 1A). In order to study the involvement of signaling
pathways in BbC50sn-DC survival, we added specific kinase
inhibitors to the culture medium 1 hour before the addition of the
different TLR agonists. The dosage of kinase inhibitors was chosen
in order to avoid a non toxicity (data not shown). The p38MAPK
inhibitor (SB203580; 20 mM) increased DC survival, whatever the
TLR agonist: BbC50sn (50%614 vs 78%614; p=0.008, n=5),
LPS (28%614 vs 69%622, p=0.008, n=4), Zymosan (56%68
vs 77%613, p=0.008, n=5) (Fig. 1B). Interestingly the DC
survival observed with LPS after addition of the p38MAPK
inhibitor was similar to that observed with BbC50sn. In contrast,
the PI3K inhibitor (LY294002; 10 mM) reduced BbC50sn-DC
survival (50%614 vs 27%69, p=0.004, n=4) (Fig. 1C), and also
LPS-DC (28%614 vs 18%611, p=0.031, n=5) and Zymosan-
DC (56%68 vs 37%612, p=0.02, n=5) survival, with a dose-
dependent effect (data not shown). The ERK inhibitor (PD98059;
25 mM) did not significantly change DC survival after LPS or
Zymosan stimulation, but reduced survival after for BbC50sn
stimulation (50%614 vs 35%65, p=0.048, n=5) (Fig. 1D). The
GSK3 inhibitor (SB216763; 10 mM) increased survival of
BbC50sn-DC (50%614 VS 85%66, p,0.001, n=4); LPS-DC
(28%614 vs 80%67, p,0.001, n=4) and Zymosan-DC (56%68
vs 88%66, p,0.001, n=4) (Fig. 1E). PI3K activation therefore
Figure 1. BbC50sn-DC survival with the PI3K, p38MAPK, ERK and GSK3 inhibitors. DCs were used either unstimulated (NS) or in the
presence of BbC50sn (100 mg/ml), LPS (50 ng/ml) or Zymosan (25 mg/ml) for 8 days. The results are expressed as: A) the percentage of cell survival
(double Annexin V and 7AAD-negative cells) without inhibitors; B, C, D, E) the percentage of cell survival as mean6SD of 5 different experiments B)
with and without SB203580 (20 mM), C) with and without PD98059 (25 mM), D) with and without LY294002 (10 mM) E) with and without SB216763
(10 mM). The effects of kinase inhibitors were compared for panel B, C, D and E with the same control data for each stimulation. Statistical analysis was
performed using the Wilcoxon test for paired non-parametric data. Significance is indicated by p value * p#0.05; **p#0.001.
doi:10.1371/journal.pone.0002753.g001
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survival. The differences observed in survival between BbC50sn-
DC and LPS-DC could be due to preferential activation of PI3K
by BbC50sn and Zymosan and preferential activation of
p38MAPK by LPS.
Maturation of BbC50sn, LPS and Zymosan-stimulated DC
was enhanced by p38MAPK and PI3K, with opposite
effects of ERK and GSK3 signaling pathways
BbC50sn induced DC maturation, with up-regulation of CD83
and CD86 in the same proportions as did LPS and Zymosan 2
days after stimulation (Fig. 2A). The p38MAPK inhibitor
(SB203580) induced a profound reduction in CD83 and CD86
DC expression after BbC50sn (83%610 vs 38%67, p,0.001,
n=6), LPS (87%67 vs 48%68, p,0.001, n=6) and Zymosan
(83%67 vs 52%69, p,0.001, n=6) stimulation (Fig. 2B). The
PI3K inhibitor (LY294002) induced a reduction in CD83 and
CD86 DC expression after BbC50sn (83%610 vs 64%615,
p=0.05, p=4), LPS (87%67 vs 60%614, p,0.001, n=4) and
Zymosan (83%67 vs 67%613, p=0.06, n=4) stimulation
(Fig. 2C). In contrast, the ERK (PD98059) and GSK3
(SB216763) inhibitors did not modify DC maturation after
BbC50sn, LPS or Zymosan stimulation, but increased maturation
of unstimulated cells (Fig. 2D; 2E). Furthermore, when sub-
optimal doses of BbC50sn, LPS or Zymosan (10 mg/ml, 5 ng/ml,
5 mg/ml, respectively) were used, the addition of ERK and GSK3
inhibitors induced full DC maturation (Fig. 2F; 2G). p38MAPK
and to a lesser extent PI3K are therefore both positively involved
in DC maturation whereas ERK and GSK3 activation inhibit DC
maturation.
Cytokine production of BbC50sn, LPS and Zymosan-
stimulated DC was differentially regulated by p38MAPK,
ERK, GSK3 and PI3K signaling pathways
Monocyte-derived DCs were activated by BbC50sn, LPS or
Zymosan and cytokine synthesis was analysed by ELISA in the
supernatant of these cultures. BbC50sn-treated DCs produced low
IL-12 and high IL-10 levels in contrast to LPS-treated DCs
(404 pg/ml6480 vs 1175 pg/ml61070, p=0.005, n=10 (Fig. 3A)
and 3444 pg/ml63700 vs 1780 pg/ml62800, p=0.007, n=10
(Fig. 3B), respectively). No significant IL-12 production was
measurable after Zymosan stimulation (Fig. 3A), whereas IL-10
production was high (3175 pg/ml64400 (Fig. 3B)). Due to the
high variability of cytokine productions between donors (Fig. 3),
we chose to express the results in percentage of the cytokine levels
measured in the absence of kinase inhibitors to analyse their effects
on IL-12 (Fig. 4) and IL-10 (Fig. 5) DC production. The
p38MAPK inhibitor (SB203580) induced a near total reduction
in IL-12 production after BbC50sn and LPS stimulation (Fig. 4B).
The GSK3 inhibitor (SB216367) also induced a reduction in IL-12
production after BbC50sn and LPS stimulation (Fig. 4E). In
contrast, the ERK inhibitor (PD98059) and the PI3K inhibitor
(LY294002) induced increases in IL-12 DC production after
BbC50sn or LPS stimulation (Fig. 4CD). Zymosan was unable to
produce measurable IL-12 levels, even in the presence of ERK
and PI3K inhibitors (Fig. 4A).
The p38MAPK inhibitor (SB203580), and to a lesser extent the
ERK inhibitor (PD98059) and the PI3K inhibitor (LY294002),
induced a significant reduction in IL-10 production by DCs after
BbC50sn, Zymosan or LPS stimulation (Fig. 5BCD). In contrast,
the GSK3 inhibitor (SB216367) induced an increase in IL-10
production after BbC50sn, LPS or Zymosan (Fig. 5E). These
results suggest that p38MAPK is positively involved in both IL-12
and IL-10 DC production, that PI3K and ERK decrease IL-12
and increase IL-10 production and that GSK3 decreases IL-10
and increases IL-12 production.
The differences in cytokine production observed between
BbC50sn- and LPS-DC (Fig. 4A, 5A) could be due to a
preferential activation of PI3K by BbC50sn as in DC survival.
But the differences observed between BbC50sn and Zymosan
(Fig. 4A, 5A) suggest that BbC50sn is also able to activate
p38MAPK although to a lesser extent. We therefore studied the
phosphorylation of Akt and p38MAPK in DC after stimulation by
BbC50sn, LPS or Zymosan. As shown in Fig. 6, BbC50sn induced
a phosphorylation of Akt similar to that observed with Zymosan,
but a phosphorylation of p38MAPK similar to that observed with
LPS.
Discussion
We have previously observed that NF-kB activation was
involved in the maturation process of DCs stimulated by a
supernatant of a Bifidobacterium fermentation product [20]. But in
contrast to Menard who reported anti-inflammatory properties of
a similar Bifidobacteria strain with decreased NFkB nuclear
translocation [27], our results, concerning a product of fermen-
tation and not the supernatant of the bacteria alone, didn’t show
modification of IL-10 production and prolonged DC survival after
NF-kB inhibition by lactacystin, suggesting the involvement of
other intracellular pathways. In the present study, we demonstrat-
ed for the first time that BbC50sn induces maturation, activation
and survival of dendritic cells via different signaling pathways. We
used kinase inhibitors mostly used in the literature in order to
compare our results with other publications. Moreover, these
inhibitors, SB203580, LY294002, PD98059, and SB216763 seem
to be the most specific inhibitors described for respectively
p38MAPK, PI3K, ERK and GSK3 [28]. We found that 1) the
PI3K pathway is positively involved in the prolonged DC survival
induced by BbC50sn whereas p38MAPK and GSK3 have
negative effects; 2) p38MAPK and PI3K are both positively
involved in DC maturation, in contrast to ERK and GSK3; 3)
PI3K and ERK are positively involved in DC-IL-10 production, in
contrast to GSK3 that is positively involved in DC-IL-12
production and p38MAPK that is positively involved in both. 4)
BbC50sn induced a PI3K/Akt phosphorylation similar to that
induced by Zymosan and a p38MAPK phosphorylation similar to
that induced by LPS. Furthermore, the preferential involvement of
some of these different pathways after BbC50sn, LPS and
Zymosan stimulation could explain the different properties
observed with these agonists.
We observed that the PI3K pathway was involved in the
prolonged DC survival measured after 8 days of stimulation by
BbC50sn. PI3K has recently been shown to be directly involved in
TLR signaling pathways, independently of the IRAK/TRAF6/
NF-kB pathway [29,30]. PI3K therefore constitutes a good
candidate for DC signaling pathway after the TLR2 engagement
by BbC50sn or Zymosan. Few studies have reported the
involvement of PI3K in DC survival. Xie et al reported that
PI3K was essential for DC survival during the differentiation of
monocytes in immature DCs, independently of any TLR
stimulation [31]. Ardeshna et al demonstrated that PI3K was
involved in myeloid DC survival by modulating the balance of
pro- and anti-apoptotic Bcl-2/Bad family proteins which could be
induced by BbC50sn, as we have previously described [20,32].
Interestingly, the same authors found that p38MAPK induced DC
survival measured 48 h after LPS stimulation, in contrast to our
results where p38MAPK decreased long term DC survival
Probiotic Signaling in DC
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This suggests that p38MAPK may have a positive effect on early
DC survival and a negative effect on long term DC survival. We
also showed for the first time that inhibition of GSK3 increased
DC survival. GSK3 is a serine protein kinase involved in
maturation, activation and apoptosis of several cells [33–35]. It
has been reported that PI3K neutralizes GSK3 activity, via Akt
phosphorylation [33]. Therefore, the prolonged DC survival that
we observed with BbC50sn could be partly the consequence of
GSK3 inhibition induced by PI3K and Akt.
We also found that p38MAPK was involved in the maturation
of DCs treated by BbC50sn. This is in accordance with previous
Figure 2. BbC50sn-DC maturation with the PI3K, p38MAPK, ERK and GSK3 inhibitors. In panel A, B, C, D and E, DCs were used either
unstimulated (NS) or in the presence of BbC50sn (100 mg/ml), LPS (50 ng/ml) or Zymosan (25 mg/ml) for 2 days. The results are expressed as A) the
percentage of CD83 and CD86 double positive cells without inhibitors; B, C, D, E) the percentage of CD83 and CD86 double positive cells as
mean6SD of 6 different experiments, B) with and without SB203580, C) with and without PD98059, D) with and without LY294002, E) with and
without SB216763 with the same inhibitors doses as in Fig 1. The effects of kinase inhibitors in panels B, C, D and E were compared with the same
control data for each stimulation. In panels F and G, DCs were used either unstimulated (NS) or in the presence of sub-optimal doses of BbC50sn
(10 mg/ml), LPS (5 ng/ml) or Zymosan (2.5 mg/ml) for 2 days, with the same inhibitors that in panels 2D and 2E respectively. The results are expressed
as the percentage of CD83 and CD86 double positive cells F) with and without PD98059, G) with and without SB216763, with the same inhibitors
doses as in Fig 1. The effects of kinase inhibitors in panels F and G were compared with the same control data for each stimulation. Statistical analysis
was performed using the Wilcoxon test for paired non-parametric data. Significance is indicated by p value :* p#0.05; **p#0.001.
doi:10.1371/journal.pone.0002753.g002
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Zymosan [32,36–38]. The p38MAPK signaling pathway positively
regulates DC maturation, with increased CD80, CD86, CD83 and
HLA-DR expression [39]. In contrast, we observed that ERK and
GSK3 inhibitors increased DC maturation after suboptimal
stimulation with either BbC50sn, LPS or Zymosan, which
confirmed that p38MAPK and ERK have opposite effects on
DC maturation [25,40,41]. We also observed that inhibition of
PI3K reduced DC maturation after BbC50sn, LPS and Zymosan
stimulation but at lower levels than with the p38MAPK inhibitor.
This suggests that PI3K is positively involved in DC maturation.
This could be due in part to the inhibition of GSK3 induced by
PI3K and Akt, because we observed that GSK3 inhibitor
increased DC maturation. Our results are in accordance with
those of Rodionova et al who recently reported that GSK3 inhibits
spontaneous DC maturation and that GSK3 activity was inhibited
by Akt after TLR engagement during the maturation process [35].
In many cases, inhibition of p38MAPK and to a lesser extent
PI3K have the same effect on DC maturation whether microbial
or non-microbial stimuli as CD40L trimers are used [42].
However, ours results suggested that the intensity of the kinase
recruitment is different between LPS or BbC50sn and Zymosan
(Fig. 2 and Fig. 6).
In terms of cytokine production, the p38MAPK and GSK3
inhibitors decreased DC IL-12 production after BbC50sn and LPS
stimulation, in contrast to PI3K and ERK inhibitors which
increased IL-12 production. These results are in accordance with
those of Agrawal et al who reported that p38MAPK is positively
involved in DC IL-12 production after LPS stimulation of human
monocyte-derived DC [25]. They observed that the magnitude
and kinetics of MAPK phosphorylation depended on the TLR
agonist involved: TLR4 activation induced a positive p38MAPK/
ERK ratio in contrast to TLR2. p38MAPK positively regulates
IL-12 production after TLR4 engagement and ERK negatively
regulates IL-12 production after TLR2 engagement. As for
maturation, p38MAPK and ERK have opposite effects on DC
IL-12 production [36,37,39,40,43]. Furthermore, we found that
GSK3 inhibitor decreased DC IL-12 production after BbC50sn
and LPS stimulation, which is in accordance with the literature
concerning monocytes and DCs [34,35]. Moreover, we observed
that the PI3K inhibitor increased IL-12 production, which could
be related to a regulatory function of this kinase in DC cytokine
production through inhibition of GSK3 [44]. Martin et al reported
that PI3K also induced ERK phosphorylation on human
monocytes after TLR2 engagement [45]. The increased DC IL-
12 production observed with the PI3K inhibitor in our study could
therefore also be the consequence of a reduction in ERK
phosphorylation.
We observed that ERK, p38MAPK and PI3K inhibitors
decreased IL-10 production. This is in accordance with several
studies which reported the role of ERK in DC IL-10 production
[37,39,40,43]. Although, ERK and p38MAPK had opposite
effects on IL-12 production, we observed that p38MAPK inhibitor
also reduced DC IL-10 production after BbC50sn, LPS and
Zymosan stimulation. Foey et al also reported that p38MAPK is
involved in monocyte IL-10 production [46] and Messmer et al
found the same effect of p38MAPK on DC IL-10 production [47].
p38MAPK could be involved in the stability of cytokine mRNA at
a post-transcriptional level, and this could explain the reduction in
both IL-12 and IL-10 production [48]. Because BbC50sn and
Figure 3. BbC50sn-DC cytokine production. DCs were stimulated with either BbC50sn (100 mg/ml) or LPS (50 ng/ml) or Zymosan (25 mg/ml) for
2 days. IL-12 (A) or IL-10 (B). Synthesis were analyzed by ELISA in the supernatant of these cultures after 48 h of stimulation. The results are expressed
in picograms per milliliter: each point represents the values of one donor for each stimulation and the heavy bar the mean of cytokine production for
each stimulus. Statistical analysis was performed using the Wilcoxon test for paired non-parametric data. Significance is indicated by p value.
doi:10.1371/journal.pone.0002753.g003
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level of IL10 production and a greater Akt phosphorylation, we
hypothesize that PI3K/Akt had a key role in the control of the IL-
10/IL-12 DC production balance (Fig. 7). This action could be
mediated by GSK3 activity which negatively regulates cAMP
response element-binding (CREB), previously described as an IL-
10 transcription factor [49]. In conclusion, few studies have
investigated the DC intracellular pathways induced by probiotic
bacteria [19]. In previous study [20], we have demonstrated that
the BbC50sn activity on maturation of DC was dependant of the
media in which BbC50 had grown. Indeed, we did saw DC
activation by BbC50sn when BbC50 had been cultured in media
containing hydrolyzed whey protein as protein source, but not in
other media in which dairy proteins contents were different (data
not shown). In addition, contrary to BbC50sn the supernatant of
BbC7 obtained by the fermentation of BbC7 in media containing
hydrolyzed whey protein was not able to trigger DC maturation.
Thus the effect of BbC50sn on DC is both media and strain-
dependant. Regarding this conclusion, we hypothesis that the
nature of the compound(s) could be : metabolite(s) produced
during the fermentation ; after dialysis, glycoproteins are the main
chemical compounds produced during fermentation and/or
bacterial fragments of which composition is modified by the
composition of the fermentation media. In this study, we report for
the first time that a fermentation product of a bifidobacteria can
differentially activate MAPK, GSK3 and PI3K in order to
modulate the maturation, activation and survival of DCs to
promote a regulatory profile. We observed that PI3K is positively
involved in the effetc of BbC50sn on 1) the prolonged DC survival;
2) the maturation; 3) the balance of IL-10/IL-12 production.
Nevertheless, the DC p38MAPK phosphorylation induced by
BbC50sn could explain some of the properties observed with this
fermentation product. Description of the differential modulation of
the intracellular signaling induced by PAMPs is important to
understand the fine-tuned balance between the maintenance of
normal mucosal homeostasis to commensal and fermentation
products of bacteria and the specific inflammatory immune
responses to pathogen bacteria. Therefore, a better knowledge of
the molecular mechanisms of signaling pathways induced by
probiotic bacteria, could allow new therapeutic strategies of
allergic and autoimmune diseases.
Methods
Medium, cytokines, monoclonal antibodies, kinase
inhibitors and reagents of cell culture
The culture medium used was RPMI 1640 (Gibco, Cergy
Pontoise, France) supplemented with 50 IU/mL penicillin,
50 IU/mL streptomycin (Gibco), 2 mM L-glutamin (Gibco) and
10% heat-inactivated fetal calf serum (FCS) (Gibco). Recombinant
Figure 4. BbC50sn-DC IL12 production with the PI3K, p38MAPK, ERK and GSK3 inhibitors. DCs were stimulated by BbC50sn (100 mg/ml)
or LPS (50 ng/ml) for 2 days. A) with and without SB203580; one representative experiment, B) with and without PD98059, C) with and without
LY294002, D) with and without SB216763 with the same inhibitor doses as in Fig 1. The results, determined by ELISA, are expressed in percentage of
the levels measured for each donor with and without inhibitors and represent 4 to 7 different experiments. Statistical analysis was performed using
the Wilcoxon test for paired non-parametric data. Significance is indicated by p value.
doi:10.1371/journal.pone.0002753.g004
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PLoS ONE | www.plosone.org 6 July 2008 | Volume 3 | Issue 7 | e2753Figure 5. BbC50sn-DC IL10 production with the PI3K, p38MAPK, ERK and GSK3 inhibitors. DCs were used in the same conditions as in
Fig 3: in the presence of either BbC50sn or LPS or Zymosan for 2 days: A) with and without SB203580 one representative experiment, B) with and
without PD98059, C) with and without LY294002, D) with and without SB216763 with the same inhibitor doses as in Fig 1. IL-10 production in culture
supernatants was determined by ELISA. The results are expressed in percentage of the levels measured for each donor with and without inhibitors of
4 to 7 different experiments. Statistical analysis was performed using the Wilcoxon test for paired non-parametric data. Significance is indicated by p
value.
doi:10.1371/journal.pone.0002753.g005
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Kingdom), GM-CSF from AbcysSA (Paris, France), LPS from
Sigma-Aldrich (St Quentin Fallavier, France) and Zymosan from
Invivogen (Toulouse, France). Kinase inhibitors, SB203580 which
directly inhibits p38MAPK activity [28,49], PD98059 which
prevents activation of MAPK kinase (MEK) upstream activators of
MAPK 3 and 1 (ERK), [50] and SB216763 which prevents
activation of GSK3 were obtained from Sigma-Aldrich (St
Quentin Fallavier, France), and LY294002 which inhibits PI3K
(prevents Akt phosphorylation) from Cell Signaling. The following
mouse anti-human mAbs were used for cytometry analysis:
fluorescein isothiocyanate (FITC)-anti-CD83 (IgG1, HB15e) and
phycoerythrin (PE)-anti-CD86 (IgG2b, HA5), purchased from
Immunotech (Marseille, France). Signaling protein phosphoryla-
tions were analyzed by FACS with monoclonal antibodies specific
for phosphorylated forms of Akt, p38MAPK and ERK (PE
coupled for Akt, Alexa 647 for p38MAPK and ERK, from Becton
Dickinson, Rungis France). Control cells were stained with
corresponding isotype-matched control mAbs (Immunotech and
Becton Dickinson). (FITC)-labeled Annexin V (5 mL/1610
5 cells)
and 7-amino actinomycin D (7-AAD, 10 mg/mL) were used for
apoptosis analysis (Becton Dickinson, Rungis, France; Sigma, St
Quentin Fallavier, France).
Production of Bifidobacterium breve supernatant
Bifidobacteria were isolated from infant stools as Bifidobacterium
breve and the strain was called C50 (BbC50). BbC50 was cultured
in the presence of hydrolyzed cow’s whey. Fermentation was
carried out at 37uC under anaerobic conditions for 15 hours. The
supernatant of the culture medium was collected by high speed
centrifugation after fermentation and concentrated by ultrafiltra-
tion (300 kDa), and then dialyzed on a 10 kDa membrane. After
concentration, the supernatant was lyophilized for use and called
BbC50sn. All the results reported here were obtained with the
same batch. BbC50sn activity was evaluated by its ability to
promote both increase in bifidobacteria and reduction of
Clostridium and Bacteroides pullulation in mouse gut [51].
Differentiation and maturation of dendritic cells
Blood of healthy volunteer donors was obtained from
cytapheresis after informed consent. Human peripheral blood
mononuclear cells (PBMC) were then isolated over Ficoll hypaque
and 2610
8 were plated in a 175 cm
2 flask in complete culture
medium. After 45 min at 37uC, nonadherent cells were discarded
and adherent cells were cultured in the presence of 25 ng/mL
recombinant human IL-4 and 1000 IU/mL GM-CSF. After 5
days, 15 to 20610
6 cells were harvested, washed and resuspended
in culture medium with IL-4 and GM-CSF. DC purity was
97.3%+/21.4 SD (determined according to CD1a positive cells
by flow cytometry). Kinase inhibitors, when mentioned, were
added 1 hour before BbC50sn (100 mg/ml), LPS (50 ng/ml) or
Zymozan (25 mg/ml). DCs were harvested after stimulation,
washed and used for cytometry analysis or functional assays.
Analysis of cell surface molecules, measurement of
apoptosis and protein phosphorylation analysis by flow
cytometry
Monocyte-derived dendritic cells were harvested and 1 to
2610
5 cells/sample were resuspended in phosphate-buffered
saline (PBS). For maturation analysis, cells were then incubated
Figure 6. BbC50sn induced both Akt and p38MAPK phosphorylations. Akt and p38MAPK phosphorylations induced by either BbC50sn or
LPS or Zymosan in DC were evaluated at different times by flow cytometry and expressed in mean fluorescence intensity (MFI) for A) Akt; B)
p38MAPK. Black histograms represent staining of phosphorylated kinases and empty or gray histograms correspond to isotype controls for Akt and
p38MAPK respectively. These results are representative of one out of 2 experiments.
doi:10.1371/journal.pone.0002753.g006
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conjugated monoclonal antibodies for 30 min at 4uC. The stained
cells were washed twice in PBS and fixed in 0.5% paraformalde-
hyde PBS solution until analysis by flow cytometry. Cell surface
expression was then analyzed using a laser flow cytometer
(FACSCantoH, BD, Mountain View, USA). Data were analyzed
for the percentage of marker-positive cells (at least 10,000 cells/
sample were analyzed using DivaH software (Becton Dickinson).
For measurement of apoptosis, DCs were incubated with
Annexin V and 7-AAD. The proportions of positive and negative
7-amino actinomycin D (7-AAD) and fluorescein isothiocyanate
(FITC)-labeled Annexin V cells were determined by flow
cytometry (FACSCantoH, Becton Dickinson). Double Annexin V
and 7AAD-negative cells corresponded to cell survival.
Signaling protein phosphorylations were studied by FACS.
Briefly, DC were incubated at 37uC with either BbC50sn or
Zymosan or LPS, then fixed and permeabilized using a
commercially available cell permeabilization reagent kit (Caltag
Laboaratories). Finally, cells were stained with specific Abs for
1 hour at room temperature, then washed once in PBS-2% human
albumin serum (HAS) and resuspended in PBS until analysis by
flow cytometry.
Cytokine quantification in culture supernatant.
Measurements of IL-12 (p70) and IL-10 levels were performed by
human enzyme-linked immunosorbent assay (ELISA) using
commercially available antibodies and standards according to the
manufacturer’s protocols (eBioscience).
Statistical analysis. Results are expressed as the
mean6standard deviation (SD) unless otherwise stated.
Comparison between samples with and without kinase inhibitors
was conducted using the Wilcoxon test for paired non-parametric
data. Analyses were performed using XLSTAT 2008 Software
V2.03. A value of p,0.05 was considered as significant.
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